Related references
Note: Only part of the references are listed.Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma
Haoyang Mi et al.
FRONTIERS IN IMMUNOLOGY (2022)
Simulations of tumor growth and response to immunotherapy by coupling a spatial agentbased model with a whole-patient quantitative systems pharmacology model
Alvaro Ruiz-Martinez et al.
PLOS COMPUTATIONAL BIOLOGY (2022)
Cell graph neural networks enable the precise prediction of patient survival in gastric cancer
Yanan Wang et al.
NPJ PRECISION ONCOLOGY (2022)
Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer
Hanwen Wang et al.
ISCIENCE (2022)
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Nasser Hosein et al.
NATURE CANCER (2022)
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
Sara A. Vayrynen et al.
CLINICAL CANCER RESEARCH (2021)
The war against pancreatic cancer in 2020-advances on all fronts
Tejeshwar Jain et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Understanding the immune response and the current landscape of immunotherapy in pancreatic cancer
Lorena Ostios-Garcia et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma
Darci Phillips et al.
NATURE COMMUNICATIONS (2021)
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
Hanwen Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer
Anna Maxi Wandmacher et al.
CANCERS (2021)
Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome
Shannon M. Liudahl et al.
CANCER DISCOVERY (2021)
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry et al.
SCIENCE (2021)
A Spatial Quantitative Systems Pharmacology Platform spQSP-IO for Simulations of Tumor-Immune Interactions and Effects of Checkpoint Inhibitor Immunotherapy
Chang Gong et al.
CANCERS (2021)
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
Yu Wang et al.
CELL DISCOVERY (2021)
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture
Haoyang Mi et al.
CELL REPORTS MEDICINE (2021)
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer
Andrew J. Gunderson et al.
ONCOIMMUNOLOGY (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Topological Tumor Graphs: A Graph-Based Spatial Model to Infer Stromal Recruitment for Immunosuppression in Melanoma Histology
Henrik Failmezger et al.
CANCER RESEARCH (2020)
The single-cell pathology landscape of breast cancer
Hartland W. Jackson et al.
NATURE (2020)
Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
Carole Siret et al.
FRONTIERS IN IMMUNOLOGY (2020)
BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Bruno Bockorny et al.
NATURE MEDICINE (2020)
Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front
Christian M. Schurch et al.
CELL (2020)
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer
Haoyang Mi et al.
FRONTIERS IN PHYSIOLOGY (2020)
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model
Huilin Ma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy
Anthony B. Rodriguez et al.
CANCER IMMUNOLOGY RESEARCH (2020)
QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications
Richard J. Sove et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2020)
Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features
Eva Karamitopoulou
BRITISH JOURNAL OF CANCER (2019)
Current Status of Immunotherapies for Treating Pancreatic Cancer
Annie A. Wu et al.
CURRENT ONCOLOGY REPORTS (2019)
Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors
Chang Gong et al.
FRONTIERS IN ONCOLOGY (2019)
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Brooke A. Pereira et al.
TRENDS IN CANCER (2019)
Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity
Logan K. Smith et al.
IMMUNITY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
Leeat Keren et al.
CELL (2018)
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A. Giraldo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
Julienne L. Carstens et al.
NATURE COMMUNICATIONS (2017)
Spatial distribution of B cells predicts prognosis in human pancreatic adenocarcinoma
Giovanni Francesco Castino et al.
ONCOIMMUNOLOGY (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Short-term and long-term risk factors in gastric cancer
Giuseppe Verlato et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma
Lixin Wang et al.
ONCOIMMUNOLOGY (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Recent progress in pancreatic cancer
Christopher L. Wolfgang et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Adjuvant treatment of pancreatic cancer
John P. Neoptolemos
EUROPEAN JOURNAL OF CANCER (2011)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Pathogen-specific CD8 T cell responses are directly inhibited by IL-10
Partha Sarathi Biswas et al.
JOURNAL OF IMMUNOLOGY (2007)
IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins
Xiaoyu Hu et al.
IMMUNITY (2006)
spatstat: An R package for analyzing spatial point patterns
A Baddeley et al.
JOURNAL OF STATISTICAL SOFTWARE (2005)
Reprogramming of IL-10 activity and signaling by IFN-γ1
C Herrero et al.
JOURNAL OF IMMUNOLOGY (2003)